Tetrabutylammonium Fluoride → (E)-N-(2-Hydroxyethyl)-4-(8-morpholino-2-(2-(quinolin-2-yl)vinyl)imidazo[1,2-a]pyrazin-5-yl)benzenesulfonamide
Reaction equation
[Si]([O:8][CH2:9][CH2:10][NH:11][S:12]([C:15]1[CH:20]=[CH:19][C:18]([C:21]2[N:26]3[CH:27]=[C:28](/[CH:30]=[CH:31]/[C:32]4[CH:41]=[CH:40][C:39]5[C:34](=[CH:35][CH:36]=[CH:37][CH:38]=5)[N:33]=4)[N:29]=[C:25]3[C:24]([N:42]3[CH2:47][CH2:46][O:45][CH2:44][CH2:43]3)=[N:23][CH:22]=2)=[CH:17][CH:16]=1)(=[O:14])=[O:13])(C(C)(C)C)(C)C.CCCC[N+](CCCC)(CCCC)CCCC.[F-]>C1COCC1>[OH:8][CH2:9][CH2:10][NH:11][S:12]([C:15]1[CH:20]=[CH:19][C:18]([C:21]2[N:26]3[CH:27]=[C:28](/[CH:30]=[CH:31]/[C:32]4[CH:41]=[CH:40][C:39]5[C:34](=[CH:35][CH:36]=[CH:37][CH:38]=5)[N:33]=4)[N:29]=[C:25]3[C:24]([N:42]3[CH2:47][CH2:46][O:45][CH2:44][CH2:43]3)=[N:23][CH:22]=2)=[CH:17][CH:16]=1)(=[O:13])=[O:14]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of compound 33a (135 mg, 0.201 mmol) in THF (5 mL), TBAF (112 mg, 0.402 mmol) was added. The resulting mixture was stirred at rt for 2 h and concentrated. The residue was purified by flash column chromatography on silica gel (EtOAc/hexanes, 0-100%). The solid obtained was suspended in 50% diethyl ether/hexanes, sonicated, and collected by filtration to obtain the title compound 73. 1H-NMR (400 MHz, DMSO-d6) δ (ppm): 7.48-7.52 (m, 2H), 7.06-7.13 (m, 6H), 6.99-7.04 (m, 2H), 6.87-6.92 (m, 1H), 6.78-6.84 (m, 1H), 6.67-6.73 (m, 2H), 3.90-3.95 (m, 1H), 3.44-3.50 (m, 4H), 2.94-2.99 (m, 4H), 2.54-2.61 (m, 4H). Mass Spectrum (LCMS, ESI pos.) Calcd. For C29H28N6O4S: 557.2 (M+H). Found 557.2.
Workup
- concentrationconcentrated
- customThe residue was purified by flash column chromatography on silica gel (EtOAc/hexanes, 0-100%)
- customThe solid obtained
- customsonicated
- filtrationcollected by filtration
Sources & evidence
- ORD record
- ord-1274951018cc459fa5131ca488a458b9
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09249163B2
Reaction notes
Loading…